Integra Lifesciences Holdings (IART) Operating Income (2016 - 2025)
Integra Lifesciences Holdings (IART) has disclosed Operating Income for 17 consecutive years, with $23.0 million as the latest value for Q4 2025.
- Quarterly Operating Income fell 35.33% to $23.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$493.4 million through Dec 2025, down 1836.48% year-over-year, with the annual reading at -$493.4 million for FY2025, 1836.55% down from the prior year.
- Operating Income hit $23.0 million in Q4 2025 for Integra Lifesciences Holdings, up from $11.8 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of $67.8 million in Q4 2022 to a low of -$512.7 million in Q2 2025.
- Historically, Operating Income has averaged $4.1 million across 5 years, with a median of $33.2 million in 2021.
- Biggest five-year swings in Operating Income: surged 268.28% in 2021 and later plummeted 16825.52% in 2025.
- Year by year, Operating Income stood at $58.2 million in 2021, then increased by 16.52% to $67.8 million in 2022, then crashed by 46.86% to $36.0 million in 2023, then dropped by 1.17% to $35.6 million in 2024, then crashed by 35.33% to $23.0 million in 2025.
- Business Quant data shows Operating Income for IART at $23.0 million in Q4 2025, $11.8 million in Q3 2025, and -$512.7 million in Q2 2025.